To compare the quality of life (QoL) in the first postoperative year after elective endovascular abdominal aortic aneurysm repair (EVAR) and open repair (OR) in a randomised study. Methods. In the Dutch Randomised Endovascular Aneurysm Management (DREAM) trial, patients are randomly allocated to EVAR or OR. QoL questionnaires (SF-36 and EuroQoL-5D) were sent to all patients preoperatively (PREOP) and at five time points in the first postoperative year (3W, 6W, 3M, 6M and 12M). Between November 1999 and August 2002, 153 patients (141 male; 12 female) were randomised (78 EVAR and 75 OR; one crossover from OR to EVAR). The EuroQoL-5D scores and the eight domains of the SF-36 for the two groups were compared using the Mann -Whitney test. Changes over time were analysed using the Wilcoxon sign test.
relatively high reintervention rate in combination with the uncertainty about the durability of EVAR might result in a reduced quality of life (QoL). Several studies have been published on this subject, however, until now there have been no randomised studies comparing the impact of EVAR and OR on the QoL. 5 -8 The aim of our study was to compare QoL in the first postoperative year after elective EVAR and OR in a randomised study.
Patients and Methods
In the Dutch Randomised Endovascular Aneurysm Management (DREAM) trial, patients suitable for both treatments are randomly allocated to EVAR or OR. The study design has been described in detail elsewhere. 9 The Institutional Review Board of all participating hospitals approved the study and informed consent was obtained from each patient. The study was funded by the Dutch Health Insurance Council (OG68).
Between November 1999 and August 2002, 153 patients (141 male; 12 female, mean age 70 years (range 53-85 yrs, SD 6.9) were treated (78 EVAR and 75 OR; one crossover from OR to EVAR). Health related quality of life was measured using the standardised Medical Outcomes Study Short-form 36-item survey (SF-36) and the EuroQol-5D. 10 -12 The SF-36 includes a multi-item scale that assesses eight health domains:
1. limitations in physical activities because of health problems (PF), 2. limitations in social activities because of physical or emotional problems (SF), 3. limitations in usual role activities because of physical health problems (RP), 4. bodily pain (BP), 5. general mental health (MH) (physiological distress and well-being), 6. limitations in usual role activities because of emotional problems (RE), 7. vitality (VT) (energy and fatigue),
general health perceptions (GH).
For each domain a score can be calculated ranging from 0 to 100, with higher scores indicating a better QoL (0 ¼ death, 100 perfect health). The EuroQol-5D consists of five questions, defining health in terms of mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Again, higher scores indicate a better QoL.
The QoL questionnaires (SF-36 and EuroQol-5D) were sent to all patients preoperatively and at five time points in the first postoperative year (3 weeks, 6 weeks, 3 months, 6 months and 12 months). If the questionnaire was not filled out completely, questions were completed with a telephone call.
Statistical Analysis
Statistical analysis was performed using SPSS version 11.0 (SPSS Inc., Chicago, IL, USA). Mean (SD) scores at baseline (preoperative values) and postoperatively were calculated for both groups. Baseline characteristics (age, gender, SVS risk score 13 ) of both trial arms were compared with student's T-test and Chi-square. Baseline scores were compared with the scores of general Dutch population of the same age.
11 A p-value of less than 0.05 was considered significant. Changes over time were analysed for each trial arm using the Wilcoxon sign test.
Changes in time in QoL scores were also calculated relative to the preoperative level. At each time point, the absolute and relative scores on the domains of SF-36 and the EuroQoL-5D for the trial arms were compared using the non-parametric Mann -Whitney test.
To assess responsiveness, a standardised response mean (effect-size) was calculated, i.e. the difference in mean scores at baseline and postoperatively divided by the standard deviation of the baseline score.
14 An effect-size of 0.2 is defined as small, one of 0.5 as moderate and one of 0.8 or greater as large. 15 
Results
There were no differences in baseline characteristics (age, gender and SVS risk factors) between EVAR and OR ( Table 1 ). The comparison of the preoperative QoL scores of the study group with the scores of the age matched Dutch population is presented in Table 2 . The QoL scores of the study group tended to be lower for several domains, but large standard deviations preclude valid statistical conclusions.
With respect to the morbidity and mortality there were no losses to follow-up in the first year. Cumulative survival at 12 months in the OR group was 89% (SD 3.5%) and 95% (SD 2.6%) in the EVAR group (p ¼ 0:21; logrank). In addition, the cumulative event free survival at 12 months was 72% (SD 5.2%) in the OR group versus 76% (SD 5.0%) in the EVAR group (p ¼ 0:49; logrank).
The preoperative questionnaire response rate was 83% in the OR group and 97% in the EVAR group (p ¼ 0:003; Chi-square). The postoperative response rates for OR and EVAR were 73% versus 97% ðp ¼ 0:049Þ at 3 weeks, 75% versus 86% ðp ¼ 0:08Þ at 6 weeks, 87% versus 93% ðp ¼ 0:238Þ at 3 months, 87% versus 95% ðp ¼ 0:097Þ at 6 months and 91% versus 94% ðp ¼ 0:346Þ at 12 months.
The changes on the domains of SF-36 (health profiles) over time for each trial arm are shown in Fig. 1 . At the 3 weeks time point the OR group showed a significant decrease compared to baseline level on six of the eight SF-36 domains (PF p , 0:001; SF p , 0:001; RP p , 0:001; RE p ¼ 0:006, VT p , 0:001; BP p ¼ 0:001, Wilcoxon sign test). The EVAR group showed a significant decrease on five of the domains of the SF-36 (PF p , 0:001; SF p , 0:001; RP p ¼ 0:001; VT p ¼ 0:006; BP p ¼ 0:01; Wilcoxon sign test). Six weeks after surgery the OR group showed a partial recovery on all the impaired domains, significantly for the PF, SF and VT (6W versus 3W, p , 0:001; p , 0:001 and The EuroQol-5D scores for groups showed a significant decrease 3 weeks after surgery (OR p ¼ 0:022; EVAR p ¼ 0:004; Wilcoxon sign test). At the 6 week time interval, both groups showed a completely recovery to baseline on EuroQol-5D. For the EVAR group EuroQol-5D scores remained at baseline level from 3 months on. The OR group was still at baseline level at 3 months, but the EuroQoL-5D showed a significant increase compared to the baseline level at the 6 and 12 months time interval (p ¼ 0:028 and p ¼ 0:002; respectively, Wilcoxon sign test).
Comparing the absolute scores at the 3 weeks time interval between the trial arms, the OR group had significantly lower scores on PF, SF and RP (p ¼ 0:026; p ¼ 0:027 and p , 0:001; respectively, Mann -Whitney test). The RP score in the OR was still significantly lower than in the EVAR group 6 weeks postoperatively (p ¼ 0:034; Mann -Whitney test). Comparing the absolute scores at 12 months between the two trial arms, the OR scored significantly higher than the EVAR group on PF ðp ¼ 0:016Þ; SF ðp ¼ 0; 017Þ; RE ðp ¼ 0:024Þ; BP ðp ¼ 0:025Þ and GH ðp ¼ 0:024Þ: The EuroQol-5D scores did not differ significantly between OR and EVAR until 6 months postoperatively. However, from that time point on the OR group showed significantly higher scores than the EVAR group (p ¼ 0:045 and p ¼ 0:001; 6M and 12M, respectively, Mann-Whitney test).
The effect-sizes for both groups are shown in Table 3 . The impact of the intervention was larger for the OR group than for the EVAR group. At 3 weeks, in the OR group the effect-sizes were classified as severe on three domains (PF, SF, RP), moderate on three domains (RE, VT, BP), no effect on MH, and a slight improvement on GH. In the EVAR group, no severe impact was measured, a moderate effect on four domains (PF, SF, RP, BP), a mild effect on three domains (RE, VT, GH) and a small improvement on MH. The impact on the EuroQol-5D was moderate in both groups at 3 weeks. Six weeks postoperatively, the impact of the intervention has decreased but is still severe on the RP, moderate on PF, SF and BP in the OR group, whereas the impact on the EVAR group has decreased to mild. On year after surgery, a positive impact is seen in the OR group on all domains and the EuroQol-5D. In the EVAR group this positive impact is also seen, except for PF, GH and EuroQol-5D.
Discussion
Although quality of life is a complex entity that is difficult to define, patient satisfaction weighs heavily in the decision which treatment is best. In contrast to the number of studies published about the medical differences between EVAR over OR, there have been only a handful of studies examining QoL. To our knowledge this is the first randomised study on QoL after EVAR and OR.
This study has shown that both EVAR and OR has an impact on the QoL, particularly in the first 3 weeks after the intervention, causing deterioration on almost all domains and also the EuroQol-5D. With regard to the physical domains, this decrease in QoL is significantly more pronounced in the OR group than in the EVAR group. Because there were no differences in survival rates or event free survival in the first year, this can be explained by the differences in invasiveness of the OR compared to EVAR. This was also shown in the study of Aquino et al., although the first postoperative measurement took place 1 week after the operation. 6 At the fourth week measurement, all scores in their EVAR group had returned to the preoperative level. At our second measurement (6 weeks postoperatively) all decreased scores, except RP and BP in the OR group, showed a partial but not complete recovery.
Lloyd et al. compared the baseline level with one postoperative measurement only, 6 months after surgery. 5 They found a significant deterioration in the domains of physical function in both groups. In our study and also in the study of Aquino, all patients had at least returned to their baseline level at that time point. An explanation for this different finding could be that Lloyd performed a paired analysis for all patients without discriminating between EVAR and OR. In addition, their endovascular group consisted of high-risk patients who were not suitable for conventional repair. On the other hand, they also compared the OR group with the EVAR group and found no significant differences. The differently chosen time intervals between these studies make comparison difficult and also emphasises the point that little is known about the changes over time.
One weakness of our study could be the difference in the preoperative and the 3-week postoperative response rate between the EVAR and OR group. We do not have an appropriate explanation for the difference in preoperative response rate. Except that for the early postoperative period it could be that more patients were too ill to fill out the questionnaires in the OR group. Even so, this would support our conclusion that there is an advantage of EVAR in the early postoperative period. Another weakness of this study is that the analysis is not longitudinal. However, missing data is inherent to a QoL study. Providing only longitudinal data would introduce a selection bias also.
In our study, the mental function showed no decrease postoperatively and even increased over time reaching significantly higher scores than the baseline in both groups. Perkins et al. also reported this. 16 A possible explanation for this is the relief of the anxiety following repair of the aneurysm.
The intensive surveillance of EVAR did not seem to result in an impaired QoL, contrary to suggestions made in the literature. 6, 17, 18 Current results cannot be explained by differences in intensity of surveillance as follow-up protocols for OR and EVAR were the same.
After 3 months, both groups had regained at least their preoperative level on all domains. It is remarkable the OR group scored significantly better than the EVAR group at 1 year postoperatively on five of the eight domains and the EuroQol-5D, whereas the groups had similar scores preoperatively. This seems to indicate there is an advantage in QoL of the OR group over the EVAR group, 1 year postoperatively. As elective repair of an AAA is treatment of an asymptomatic condition, it is by definition hard to actually improve the QoL. As the preoperative QoL in our study group was lower on several domains of the SF-36 than the scores of the general population, this may indicate that the knowledge of having a potentially life-threatening disease does have an impact on the QoL. The increase in QoL 1 year after AAA repair has been described in other QoL studies, mostly in the OR group, but also in studies on QoL after other major abdominal surgery. 8, 16, 18, 19 An explanation may be that people experience a relatively better QoL after a period of severe illness or major surgery.
Conclusion
In the early postoperative period there is a small yet significant QoL advantage of EVAR compared to OR. At 6 months and beyond, patients reported a better QoL after OR than after EVAR.
